Muhammad Asif, Syed Ali Raza, Muhammad Kamran Khan et al.
Food Science & Nutrition (Wiley) • Apr 16, 2025
Fatiha RA, Ngabdi CK, Azizah JS, Putri BSN, Lestari B, Malek NANN, Susanto H, Riawan W, Permatasari HK
Fatiha RA, Ngabdi CK, Azizah JS et al. (2026). Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.. Asian Pacific journal of cancer prevention : APJCP.
This laboratory study investigated whether silver nanoparticles made from moringa leaf powder could fight cervical cancer cells. Researchers treated HeLa cervical cancer cells with different concentrations of these special nanoparticles and observed what happened. They found that the moringa-silver nanoparticles significantly reduced the cancer cells' ability to move and spread, which is important because cancer becomes more dangerous when cells can migrate to other parts of the body. The treatment also reduced the production of specific proteins called Snail and vimentin, which are involved in helping cancer cells change shape and become more mobile. The effects were stronger with higher concentrations of the nanoparticles. However, this research was conducted only in laboratory dishes using one type of cancer cell line that doesn't naturally spread to other locations. While the results suggest that moringa leaf powder combined with silver nanoparticles might have potential as a cancer treatment, much more research is needed, including studies with different types of cancer cells and eventually animal and human studies, before any conclusions can be drawn about real-world applications.
Population
HeLa cervical cancer cell line
Plant part
Leaf
Preparation
Powder
Dosage
2, 4, and 6 μg/mL concentrations of MOLP-AgNPs
MOLP-AgNPs applied at 2, 4, and 6 μg/mL concentrations to cell cultures
Muhammad Asif, Syed Ali Raza, Muhammad Kamran Khan et al.
Food Science & Nutrition (Wiley) • Apr 16, 2025
Anaya-Esparza L.M., Villagrán-de la Mora Z., Ruvalcaba-Gómez J.M. et al.
F1000Research • Jan 30, 2025
Al-Rasheed N.M., Al-Otaibi M.M., Krychowiak M. et al.
Frontiers in Immunology • Jun 5, 2025